Project Grant HT94252510955
Award Date 8/15/25
Completion Date 8/14/28
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The federal Project Grant award of $992,302 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation". MGH, a...
- This federal Project Grant award of $382,381 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. The award period runs from September 1, 2025 to August 31, 2028. The grant supports advanced biomedical research by MGH aimed at developing innovative genetic immunodetection and treatment approaches for VCA (vascularized...
- The federal Project Grant award of $999,806.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to study innate lymphoid cells as new targets to reduce vascularized composite tissue transplant rejection. The award, which runs from September 30, 2024 to September 29, 2027, will enable MGH to conduct innovative biomedical research,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research,...
- This $1,644,309 Project Grant was awarded on February 1, 2025 by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420), to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will focus on functional molecular networks...
- The Massachusetts General Hospital was awarded a $999,792 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into regulatory T-cell expansion and immune modulation in vascularized composite tissue transplants from September 15, 2021 through September 14, 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,234,505 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research titled "COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS". The award, funded through the Military Medical Research and Development program (CFDA 12.420), aims to transform healthcare for military service members,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital, was awarded a $302,801 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from September 1, 2022 to August 31, 2025 to advance a tissue oxygenation measurement device and evaluate galectin-3 as novel noninvasive prognostic biomarkers for monitoring vascularized composite...
- The Department of the Army Medical Command awarded a $1,248,949 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research into stable mixed chimerism and tolerance of vascularized composite allografts via BCL-2 inhibition from September 30, 2022 to August 31, 2025. The Military Medical Research and Development program supports innovative biomedical research with the goals of improving military and public health...